Skip to main content

Epigenetics Interest Group

Epigenetics represents a new frontier in cancer research. Information in the genome exists in at least two forms, genetic and epigenetic. The genetic information provides the blue print for the manufacture of all the proteins necessary to create a living organism, whereas the epigenetic information provides additional instructions on how, where, and when the genetic information will be used. The focus of the Epigenetics Interest Group is on applications of epigenetic approaches in disease detection, risk assessment and treatment. The group meets on last Thursday of every month from 3-4 pm. Please contact Dr. Mukesh Verma at 240-276-6889 for more information.

Colleagues interested in epigenetics may benefit from fall 2019 classes offered by the Foundation for Advanced Education in the Sciences (FAES) at NIH:

BIOF509 Applied Machine Learning
BIOF518 Theoretical and Applied Bioinformatics
BIOL222 Genomics in Modern Society (Online-Hybrid)
BIOL425 RNA Interference and CRISPR (7 weeks)
GENE500 Introduction to Medical Genetics I
GENE505 Embryology, Developmental Biology, and Human Malformations
GENE510 Genetic Counseling: Professional Topics Seminar
IMMU419 Cancer Immunotherapy
See for more information.

Please join us for...

Chromatin and Cell Fate Decisions in Development, Aging & Cancer 
A conference organized by the Center of Excellence in Chromosome Biology
Registration and Abstract Submission Now Open!
Date: November 14–15, 2019
Location: Natcher Conference Center, Building 45, Ruth L. Kirschstein Auditorium
Event Website:

Chromatin Organization and Dynamics
Chromatin Reprogramming During Development
Chromatin in Cancer and Aging
Chromatin as a Therapeutic Target

Genevieve Almouzni, Ph.D. The Institut Curie
Stephen Baylin, M.D., Johns Hopkins School of Medicine
Bradley Bernstein, M.D., Ph.D., Massachusetts General Hospital
Ibrahim Cisse, Ph.D., Massachusetts Institute of Technology
Jean Gautier, Ph.D., Columbia University Irving Medical Center
Shiv Grewal, Ph.D., Center for Cancer Research, NCI
Konrad Hochedilinger, Ph.D., Howard Hughes Medical Institute, Harvard University
Cigall Kadoch, Ph.D., Dana-Farber Cancer Institute, Harvard Medical School
Tom Misteli, Ph.D., Center for Cancer Research, NCI
Tom Muir, Ph.D., Princeton University
Geeta Narlikar, Ph.D., University of California, San Francisco
Clodagh O'Shea, Ph.D., Salk Institute for Biological Studies
Jennifer Phillips-Cremins, Ph.D., University of Pennsylvania
Kathrin Plath, Ph.D., University of California Los Angeles
Danny Reinberg, Ph.D., New York School of Medicine
Bing Ren, Ph.D., University of California San Diego
Paola Scaffidi, Ph.D., The Francis Crick Institute
Ali Shilatifard, Ph.D., Northwestern University
Carol Thiele, Ph.D., Center for Cancer Research, NCI
Kenneth Zareth, University of Pennsylvania
Keji Zhao, Ph.D., National Heart, Lung, and Blood Institute, NIH
Leonard Zon, Ph.D., Harvard Medical School

Abstract Deadline is October 18, 2019
Registration Deadline is October 31, 2019
Organizing Committee: Mirit Aladjem, Ph.D. and Michael Bustin, Ph.D.

Online registration and abstract submission information can be found at Registration is free, but seating is limited so be sure to register early! For conference-related questions, please contact



The page was last updated on Thursday, August 8, 2019 - 5:50pm